glp-1 shortage news today november 2025 Novo's Wegovy and Ozempic removed from US FDA list, compounders on notice glp-1 shortages news november 2025

Goldenberg RM

But the data doesn't back up that claim, Ramachandran said

For education only verify your vial label before use

Men were three times more likely than women to say they felt more confident in their appearance and that they were getting more matches on dating apps

Among the current options, Wegovy can help people lose an average of 10 percent of their body weight in a year, while people taking Zepbound have had about a 15 percent loss, on average, in the same period

There is a theoretical risk of medullary thyroid carcinoma based on rodent studies, leading to a boxed warning and contraindication in patients with personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2